Abstract
Objective
Sialocele that develops after parotid surgery often prolongs the treatment period
and stresses both the surgeon and patient. The extent of surgery and tumor size are
known to be associated with sialocele occurrence. We investigated the incidence of
post-parotidectomy sialocele and the associated risk factors, with a focus on tumor
size.
Methods
We retrospectively reviewed the medical records of 172 patients who underwent parotidectomy
between January 2013 and May 2020 at Haeundae Paik Hospital, Inje University of Korea.
We stratified patients into those with and without sialocele (fluid collection in
the operative bed). We compared clinical data, patient demographics, and surgical
details; we identified risk factors for sialocele development after parotid surgery.
Results
Seventeen patients were diagnosed with post-parotidectomy sialocele (9.88%; 17/172).
Univariate logistic regression revealed that the male sex, deep lobe tumor location,
and large tumor size were significantly associated with postoperative sialocele (p = 0.015,
0.009, and 0.016, respectively). We subjected these parameters to multivariate analyses;
the odds ratios were 3.70, 3.58, and 2.34, respectively. Receiver operating characteristic
curve analyses showed that a tumor size > 2.50 cm was the optimal cutoff in terms
of predicting post-parotidectomy sialocele.
Conclusion
Male sex, a tumor in the deep lobe, and large tumor size were strongly associated
with increased risk for sialocele after parotidectomy. Tumor size > 2.50 cm serves
as the cutoff identifying patients likely to experience sialocele after parotid surgery.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Auris Nasus LarynxAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Sialocele after parotid surgery: assessing the risk factors.Otolaryngol Head Neck Surg. 2012; 147: 489-492
- Management of parotid sialocele with botulinum toxin.Laryngoscope. 1999; 109: 1344-1346
- The incidence and management of siaolocele after parotidectomy.Otolaryngol Head Neck Surg. 2009; 140: 871-874
- Parotidectomy: review of treatment and outcomes.ANZ J Surg. 2004; 74: 563-568
- Postoperative complications after extracapsular dissection of benign parotid lesions with particular reference to facial nerve function.Laryngoscope. 2010; 120: 484-490
- Prevalence and risk factors of sialocele formation after partial superficial parotidectomy: a multi-institutional analysis of 357 consecutive patients.Head Neck. 2016; 38 (Suppl): E941-E944
- The surgical approaches to the treatment of parotid pleomorphic adenomas.Controversies in the management of salivary gland disease. Oxford University Press, Oxford2001: 57-63
- Role of extracapsular dissection in surgical management of benign parotid tumors.JAMA Otolaryngol Head Neck Surg. 2014; 140: 768-769
- The extended indication of parotidectomy using the modified facelift incision in benign lesions: retrospective analysis of a single institution.World J Surg. 2011; 35: 2228-2237
- The diagnostic value of cytology in parotid Warthin's tumors: international multicenter series.Head Neck. 2020; 42: 522-529
- Long-term results of morbidity after parotid gland surgery in benign disease.Laryngoscope. 2010; 120: 724-730
- Retrospective review of 242 consecutive patients treated surgically for parotid gland tumours.J Otolaryngol Head Neck Surg. 2008; 37: 340-346
- Use of allogenic acellular dermal matrix in prevention of Frey's syndrome after parotidectomy.Br J Oral Maxillofac Surg. 2008; 46: 649-652
- The role of partial parotidectomy for benign parotid tumors: a case-control study.Acta Otolaryngol. 2015; 135: 718-721
- Polyglycolic acid felt for prevention of frey syndrome after parotidectomy.Ann Plast Surg. 2018; 81: 438-440
- Effect of autologous platelet adhesives on dermal fat graft resorption following reconstruction of a superficial parotidectomy defect: a double-blinded prospective trial.Head Neck. 2009; 31: 521-530
- Impact of extent of parotid resection on postoperative wound complications: a prospective study.Head Neck. 2015; 37: 64-68
- Complications after parotid gland surgery Our experience.Ann Ital Chir. 2017; 88: 295-301
- Age, sex and contralateral differences in the volumes of human submandibular salivary glands.Arch Oral Biol. 1975; 20: 885-887
- The importance of sialography for the determination of the parotid flow. The normal variation in salivary output in relation to the size of the gland at stimulation with citric acid.Acta Otolaryngol. 1971; 72: 437-444
- Variability of the submandibular flow rate in man with special reference to the size of the gland.Odontol Revy. 1972; 23: 411-420
- The influence of gland size on the flow rate and composition of human parotid saliva.Dent J. 1978; 44: 21-25
- Use of botulinum toxin type A in a case of persistent parotid sialocele.Hong Kong Med J. 2003; 9: 293-294
- The use of tissue sealant in parotidectomy – a systematic review and meta-analysis.Authorea Preprints, 2020
- Tisseel to reduce postparotidectomy wound drainage: randomized, prospective, controlled trial.J Otolaryngol. 2006; 35: 36-39
- The role of botulinum toxin in postparotidectomy fistula treatment. A technical note.Am J Otolaryngol. 2006; 27: 221-224
- A pilot study evaluating the treatment of postparotidectomy sialoceles with botulinum toxin type A.Arch Otolaryngol Head Neck Surg. 2000; 126: 421-424
- Botulinum toxin treatment of salivary fistulas following parotidectomy: follow-up results.Oral Maxillofac Surg. 2013; 17: 281-285
- Treatment of an acute salivary fistula after parotid surgery: botulinum toxin type A injection as primary treatment.Eur Arch Otorhinolaryngol. 2008; 265: 243-245
- Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.Laryngoscope. 2004; 114: 1856-1860
- Transdermal scopolamine for the prevention of a salivary fistula after parotidectomy.Br J Oral Maxillofac Surg. 2018; 56: 212-215
- Use of scopolamine patches in patients treated with parotidectomy.J Craniofac Surg. 2014; 25: e88-e89
- Transdermal scopolamine in the management of postparotidectomy salivary fistula.Ear Nose Throat J. 2013; 92: 516-519
Article info
Publication history
Published online: March 14, 2023
Accepted:
February 28,
2023
Received:
July 17,
2022
Publication stage
In Press Corrected ProofIdentification
Copyright
© 2023 Japanese Society of Otorhinolaryngology-Head and Neck Surgery, Inc. Published by Elsevier B.V. All rights reserved.